Table 1 Baseline demographic and laboratory features of subjects and follow-up duration
Baseline feature/lab value | Median (interquartile range) |
|---|---|
Total number of subjects | 81 |
Male (%) | 77 (95.1) |
Age (years) | 36 (28 to 45) |
Duration since transmission at baseline (days) | 100 (54 to 153) |
Blood CD4+ T-cells (cells/μL) | 552 (389 to 720) |
Plasma HIV RNA (log10 copies/mL) | 4.56 (3.97 to 5.18) |
CSF HIV RNA (log10 copies/mL) | 2.77 (1.80 to 3.47) |
Plasma neopterin (nmol/L) | 15.1 (9.4 to 21.6) |
CSF neopterin (nmol/L) | 10.2 (6.6 to 21.3) |
% Blood CD4 + CD38 + HLA-DR + a | 7.5 (6.2 to 11.6) |
% Blood CD8 + CD38 + HLA-DR + a | 55.3 (47.4 to 68.1) |
% CSF CD4 + CD38 + HLA-DR + a | 14.2 (8.5 to 22.2) |
% CSF CD8 + CD38 + HLA-DR + a | 70.9 (60.9 to 80.6) |
Total number of visits | 2 (1 to 3) |
Duration of follow-up (days) | 321 (105 to 727) |